ASIA-PACIFIC CRISPR MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

ASIA-PACIFIC CRISPR MARKET 2019-2028

Market By Product, Application And End-user | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research, in its report on the CRISPR market in the Asia-Pacific region, has determined that the market is expected to expand at a CAGR of 25.67% during the forecasted years 2019-2028.



We provide additional customization based on your specific requirements. Request For Customization

The countries studied in the Asia-Pacific CRISPR market are:

           South Korea

           China

           ASEAN countries

           Japan

           India

           Australia & New Zealand

           Rest of APAC countries

In China, scientists have already used CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats) to modify human embryos, clone a dog and splice genes in mice and monkeys. Few American biotechnological firms have been exporting CRISPR technology for scientific discovery across the world. These companies are focusing customers, particularly in China, as the country is conducting civilian research work and development work of sinister military applications using this technique. Extensive gene-editing research is being carried out in China, with difficulty in determining whether this research work falls under civilian, defense or military segments. Institutions similar to DARPA (Defense Advanced Research Projects Agency) in the US, handle medical studies and are rigorously pumping out research for CRISPR.

It is reported that the military scientists in China are using the CRISPR technique to generate proteins of human blood, named albumin, in baby pigs. They are also working on Hepatitis-B virus DNA with CRISPR. These researchers are enhancing the CRISPR gene-splicing technique with light-induced systems. Studies are also focusing on improving cancer drug resistance with the help of CRISPR. These developments in the country are likely to instigate the demand for the CRISPR market, thereby increasing the market growth in the coming period.

Established in 1897, Lonza is a Switzerland-based chemical and biotechnology company.  The company produces fine organic chemicals, active ingredients, biocides and biotechnology products. It offers its products to the pharmaceutical, academic, biotechnology and government research sectors through manufacturers, consumers, distributors and service companies. The company operates in different regions, including the Asia-Pacific.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC CRISPR MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. VALUE CHAIN OUTLOOK

2.5. SUPPLY CHAIN OUTLOOK

2.6. TIMELINE OF CRISPR MARKET

2.7. PARENT MARKET OUTLOOK

2.8. KEY INSIGHT

2.9. MARKET ATTRACTIVENESS INDEX

2.10.  MARKET DRIVERS

2.10.1.  GROWING LIFESTYLE-ORIENTED DISEASES

2.10.2.  SURGING PREVALENCE OF GENETIC DISEASES

2.10.3.  INCREASING APPLICATION OF DRUGS

2.10.4.  RISING AGING POPULATION

2.10.5.  INCIDENCE OF GENETIC AILMENTS

2.11.  MARKET RESTRAINTS

2.11.1.  ETHICAL AND SOCIAL ISSUES ASSOCIATED WITH CRISPR TECHNOLOGY

2.11.2.  CHANGING REGULATORY ENVIRONMENT

2.12.  MARKET OPPORTUNITIES

2.12.1.  INCREASED DEMAND FOR CRISPR  

2.12.2.  ADVANCEMENTS IN THE APPLICATIONS OF GENE-BASED THERAPY

2.13.  MARKET CHALLENGES

2.13.1.  ALTERNATIVE TECHNOLOGIES

2.13.2.   LACK OF AWARENESS REGARDING THE TECHNOLOGY

3.    CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGN TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4.    CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. GRNA DATABASE/GENE LIBRARY

4.3. CRISPR PLASMID

4.4. HUMAN STEM CELLS

4.5. CELL LINE ENGINEERING

5.    CRISPR MARKET OUTLOOK - BY END-USER

5.1. THERAPEUTICS & DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6.    CRISPR MARKET – ASIA-PACIFIC

6.1. INDIA

6.2. CHINA

6.3. JAPAN

6.4. SOUTH KOREA

6.5. AUSTRALIA & NEW ZEALAND

6.6. ASEAN COUNTRIES

6.7. REST OF ASIA-PACIFIC

7.    COMPANY PROFILE

7.1. ADDGENE

7.2. APPLIED STEMCELL

7.3. CARIBOU BIOSCIENCES INC

7.4. CELLECTIS

7.5. CRISPR THERAPEUTICS

7.6. DIACARTA

7.7. EDITAS MEDICINE

7.8. GENECOPOEIA INC

7.9. GENEDATA AG

7.10. GENSCRIPT

7.11. HORIZON DISCOVERY LTD

7.12. INTEGRATED DNA TECHNOLOGIES INC

7.13. INTELLIA THERAPEUTICS INC

7.14. LONZA  

7.15. NEW ENGLAND BIOLABS  

7.16. ORIGENE TECHNOLOGIES INC

7.17. PRECISION BIOSCIENCES

7.18. SANGAMO THERAPEUTICS

7.19. SIGMA-ALDRICH (MERCK KGAA)

7.20. THERMO FISHER SCIENTIFIC INC

7.21. TRANSPOSAGEN BIO (HERA BIOLABS)

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        ASIA-PACIFIC CRISPR MARKET, 2019-2028 ($ MILLION)

TABLE 2        CHIEF CONCERNS RELATED TO GENETIC ENGINEERING

TABLE 3        ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 4        TOOL NAMES AND THEIR PROVIDERS

TABLE 5        ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 6        BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET

TABLE 7        AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 8        ASIA-PACIFIC CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 9        ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      ASIA-PACIFIC CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSIS

FIGURE 3      ASIA-PACIFIC CRISPR MARKET, BY PLASMIDS, 2019-2028 ($ MILLION)

FIGURE 4      ASIA-PACIFIC CRISPR MARKET, BY VECTORS, 2019-2028 ($ MILLION)

FIGURE 5      ASIA-PACIFIC CRISPR MARKET, BY PROTEINS, 2019-2028 ($ MILLION)

FIGURE 6      ASIA-PACIFIC CRISPR MARKET, BY DESIGN TOOLS, 2019-2028 ($ MILLION)

FIGURE 7      ASIA-PACIFIC CRISPR MARKET, BY GRNA, 2019-2028 ($ MILLION)

FIGURE 8      ASIA-PACIFIC CRISPR MARKET, BY CONTROL KITS, 2019-2028 ($ MILLION)

FIGURE 9      ASIA-PACIFIC CRISPR MARKET, BY LIBRARY, 2019-2028 ($ MILLION)

FIGURE 10   ASIA-PACIFIC CRISPR MARKET, BY OTHER PRODUCTS, 2019-2028 ($ MILLION)

FIGURE 11   ASIA-PACIFIC CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 12   ASIA-PACIFIC CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2019-2028 ($ MILLION)

FIGURE 13   ASIA-PACIFIC CRISPR MARKET, BY CRISPR PLASMID, 2019-2028 ($ MILLION)

FIGURE 14   ASIA-PACIFIC CRISPR MARKET, BY HUMAN STEM CELLS, 2019-2028 ($ MILLION)

FIGURE 15   ASIA-PACIFIC CRISPR MARKET, BY CELL LINE ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 16   ASIA-PACIFIC CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2019-2028 ($ MILLION)

FIGURE 17   ASIA-PACIFIC CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2019-2028 ($ MILLION)

FIGURE 18   ASIA-PACIFIC CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 19   ASIA-PACIFIC CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 20   ASIA-PACIFIC CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 21   INDIA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 22   CHINA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 23   JAPAN CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 24   SOUTH KOREA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 25   AUSTRALIA & NEW ZEALAND CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 26   ASEAN COUNTRIES CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 27   REST OF ASIA-PACIFIC CRISPR MARKET, 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;